Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antitubercular Agents

"Antitubercular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.


This graph shows the total number of publications written about "Antitubercular Agents" by people in Harvard Catalyst Profiles by year, and whether "Antitubercular Agents" was a major or minor topic of these publication.
Bar chart showing 556 publications over 30 distinct years, with a maximum of 59 publications in 2012
To see the data from this visualization as text, click here.
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.